cytokinetics inc (CYTK:NASDAQ CM)
John C. Chabala Ph.D.
Member Scientific Advisory Board, Cytokinetics, Incorporated
|Age||Total Calculated Compensation||This person is connected to 70 board members in 7 different organizations across 7 different industries.|
See Board Relationships
Dr. John C. Chabala, also known as Jack, PhD founded and served as President of Pharmacopeia, Inc. from 1993 to 1996 and its Chief Scientific Officer from 1993 to 1997. Prior to joining Pharmacopeia, Dr. Chabala served as a Vice President of Discovery Chemistry at Bristol-Myers Squibb from 1991 to 1993, where he was responsible for all medicinal chemistry research worldwide in 25 programs in cardiovascular diseases, oncology, immunology and inflammation, metabolic diseases, ...
280 East Grand AvenuePhone: 650-624-3000
South San Francisco, California 94080
Board Members Memberships*There is no Board Members Memberships data available.
Massachusetts Institute of Technology
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Paolo Pucci||Chief Executive Officer and Director|
|James A. Bianco M.D.||Principal Founder, Chief Executive Officer, President and Executive Director|
Cell Therapeutics, Inc.
|Daniel R. Passeri MSc., J.D.||Chief Executive Officer and Director|
|Adelene Q. Perkins||Chairman of The Board, Chief Executive Officer and President|
Infinity Pharmaceuticals, Inc.
|$536.0K||Compensation as of Fiscal Year 2012.|
Post a JobJobs
- New York, NY | JPMorgan ChasePosted: Dec 06
- Alexandria, VA |Posted: Dec 06
- Detroit, MI | Wayne State UniversityPosted: Nov 26
- New York, NY | AGORAPosted: Nov 25